Trials with Tunlametinib
Every colorectal cancer trial that includes this drug. Those looking for patients come first.
Showing 1–1 of 1
NCT06008119
This is a multicenter, randomized, open-label, Phase 3 study
Every colorectal cancer trial that includes this drug. Those looking for patients come first.
Showing 1–1 of 1
NCT06008119
This is a multicenter, randomized, open-label, Phase 3 study